1Schieppati A, Mosconi L, Pema A et al. Prognosis of untreated patients with idiopathic membranous nephropathy, N EnglJ Med, 1993 ; 329 : 85 - 89.
2Ponticelli C, Zuchelli P, Passefini Petal. A 10 -year fol- low - up of a randomized study with methylprednisolone and ehlorambucil in membranous nephropathy. Kidney Int, 1995 ; 48 : 1600 - 1604.
3du Bur- Vereijken PW, Branten A J, Wetzels JF. Idiopathic membranous nephroathy : outlineand rationale of a treatment strategy. Am J KidneyDis, 2005; 46:1012 - 1029.
4Muirhead N. Management of idiopathic membranous nephropathy : evidence - based recommendations. Kidney Int, 1999;S70: S47 - S50.
5Cattran D. Management of membranous nephropathy: when and what for treatment. J AmSoc Nephrol, 2005; 16:1188 - 1194.
6Cameron J S, HealyMJ, Adu D. The Medical Research Council trial of short - term high - dose alternate day predniselone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomenllonephritis Working Party. Q J Med, 1990; 74 (274) : 133 -156.
7Shiiki H, Saito T, Nishitani Yet al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotie syndrome in Japan. Kidney Int, 2004 ; 65 (4) : 1400 -1407.
8Kimura M, Toyoda M, Kobayashi K et al. A retrospective study on the efficacy of eortieosteroid- alone therapy in membranous nephropathy patients. Intern Med, 2007; 46 (19) : 1641 -1645.
9Pontieelli C, Altieri P, Scolari F et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Socnephrol, 1998 ; 9 : 444 - 450.
10Pema A, Schieppati A, Zamora Jet al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis, 2004; 44 (3) : 385 -401.
7Sahin GM,Sahin S,Kantarci G,et al.Mycophenolate mofetil Treatment for therapy-resistant glomerulopathies.Nephroiogy(Carl-ton),2007,12(3):285-288.
8Appel GB,Radhakrishnan J,Ginzler EM.Use of mycophenolate mofail in autoimmune and renal diseases.Translantaion,2005,80(suppl 2):S265-S271.
9Cattran DC, Alexopoulos E, Ponticelli C, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations [ J ]. Kidney Int ,2007,72 ( 12 ) : 1429 - 1447.
10Schieppati A, Perna A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome [ J ]. Coehrane Database Syst Rev,2004,18 (4) :CD004293.
